Maze Therapeutics, Inc. · NASDAQ:MAZE
Matrix Capital Management Company, LP reported a 5.70% stake in Maze Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 14, 2025
Matrix Capital Management Company, LP reported a 5.70% stake in Maze Therapeutics, Inc., 2,486,184 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 2,486,184
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Matrix Capital Management Company, LP | 5.70% | 2,486,184 |
| David E. Goel | 5.70% | 2,486,184 |
Source
Related
- Maze Therapeutics, Inc.
- Matrix Capital Management Company, LP
- Maze Therapeutics, Inc. shareholders
- Schedule 13G/A · Matrix Capital Management Company, LP · Nov 13, 2025
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026